NCT04713930View on ClinicalTrials.gov

A Study of JNJ-61393215 in Healthy Japanese Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 29, 2021

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Healthy
Interventions
DRUG

JNJ-61393215

JNJ-61393215 will be administered orally.

DRUG

Placebo

Placebo will be administered orally.

Trial Locations (1)

812-0025

Souseikai Hakata Clinic, Fukuoka

Sponsors
All Listed Sponsors
lead

Janssen Pharmaceutical K.K.

INDUSTRY

NCT04713930 - A Study of JNJ-61393215 in Healthy Japanese Male Participants | Biotech Hunter | Biotech Hunter